MESOTHELIOMA, MALIGNANT
Clinical trials for MESOTHELIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for rare lung cancer
Disease control CompletedThis study tested whether adding a low-dose chemotherapy drug to radiation before surgery could boost the immune system's ability to fight mesothelioma, a rare cancer of the lung lining. Thirty adults with good overall health took part. After surgery, some also received two immun…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 08:40 UTC
-
Immunotherapy duo shows promise against rare lung cancer in chinese trial
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) works better than standard chemotherapy for Chinese patients with advanced pleural mesothelioma, a rare cancer of the lung lining. About 102 patients with inoperable disease took part. T…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 22, 2026 13:54 UTC